Summary by Futu AI
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.